CRESCENT BIOPHARMA, INC.
For the period ended Nov 6, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Nov 6, 2025 · Filed Nov 6, 2025
Use the contents to explore the available documents and sections.
CBIO$13.54+4.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · References:
References:
Xiong A, et al. Lancet. 2025; 405(10481):839-849.
Zhong T, et al. iScience. 2024; 28(3):111722.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.